http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-597405-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C15-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C11-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C11-00 |
| filingDate | 2012-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_909e6e69833b2757b6ec3a8c9aef8160 |
| publicationDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-597405-A |
| titleOfInvention | Shark-derived squalene containing low levels of polychlorinated biphenyl contaminants for use in vaccine adjuvants |
| abstract | Disclosed is an oil-in-water emulsion adjuvant comprising shark-derived squalene, wherein the emulsion comprises less than 661 picograms of polychlorobiphenyls (PCBs) per gram of squalene expressed as a toxic equivalent (TEQ). Also disclosed are emulsions which contain no hexachlorobiphenyl, pentachlorobiphenyl, or tetrachlorobiphenyl. The emulsions are useful in the preparation of vaccines and other treatment compositions for prevention or treatment of influenza virus, a human immunodeficiency virus (HIV), hookworm, hepatitis B virus, herpes simplex virus, rabies virus, respiratory syncytial virus, cytomegalovirus, Staphylococcus aureus, chlamydia, SARS coronavirus, varicella zoster virus, Streptococcus pneumoniae, Mycobacterium tuberculosis, Bacillus anthracis, Neisseria meningitidis, Epstein Barr virus or human papillomavirus. |
| priorityDate | 2012-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 343.